Steven Madden Ltd
SHOO
$42.70
+0.40%
Steven Madden Ltd designs, sources, and markets branded and private-label footwear, accessories, and apparel, operating through four segments — Wholesale Footwear (the largest), Wholesale Accessories/Apparel, Direct-to-Consumer, and Licensing — with the majority of revenue generated in the United States. The company occupies a distinctive position as a trend-driven, fashion-forward footwear house with accessible price points, spanning wholesale distribution to department stores and mass merchants alongside a growing owned retail and e-commerce channel, plus licensed brands including Steve Madden, Betsey Johnson, and Kurt Geiger. The current investor debate centers on a sharp post-earnings selloff following Q3 results that beat estimates on strong domestic growth but revealed lagging international and direct-to-consumer sales, raising questions about the durability of the top-line trajectory. Offsetting this, the Dolce Vita brand is building momentum across channels and management raised 2026 revenue guidance, creating a tension between near-term execution concerns and a constructive medium-term brand story that has left the stock range-bound and the analyst community divided on timing.…
SHOO
Steven Madden Ltd
$42.70
Related headlines
Investment Opinion: Should I buy SHOO Today?
Rating: Hold with a constructive bias — accumulate on confirmation. The core thesis is that SHOO is a margin-recovery story priced at a trough multiple: at $39.50 the stock trades at 14.52x forward EPS of $3.13 versus a distorted 66.1x trailing PE, while the 9-analyst consensus is "buy" (7 Buy / 1 Hold / 1 Sell, mean 2.0) with a $52.11 average target implying roughly 32% upside. The Street is right on the forward math but early on timing, given the 17% post-earnings gap-down and the failure to reclaim $40.
Supporting evidence is genuinely mixed but tilts positive on valuation. Revenue grew 15.68% YoY in Q3 2026 ($772.6M vs. $667.9M) and accelerated sequentially through the year ($649.7M → $665.9M → $772.6M), tracking toward the $2.86B consensus. Profitability improved sharply YoY — Q3 gross margin of 44.56% and operating margin of 9.48% versus 41.53% and 4.70% a year earlier — and TTM free cash flow of $213.6M on a $2.95B market cap implies a ~7.2% FCF yield, backed by a 1.90 current ratio and 0.56 debt-to-equity. Against that, the 1.17x PS and 1.11x EV/Sales are near the bottom of the multi-year 3.0x-6.2x range, and the 32% implied upside to the average target exceeds the distance to the $49.70 52-week high.
Three risks could invalidate the thesis: margin fragility (TTM operating margin of just 2.73%, with quarterly swings from 14.73% in Q1 2026 to 5.90% in Q2), channel concentration in a US wholesale/DTC mix where international and DTC lagged in Q3, and a payout ratio of 1.36 that leaves the 2.07% dividend uncovered by earnings. This Hold would upgrade to Buy if the stock reclaims $42-44 on volume and the next print shows DTC stabilization with gross margin holding above 44%; it would downgrade to Sell if gross margin slips back toward Q4 2025's 42.43% or revenue growth decelerates below 10%. Verdict: fairly valued to modestly undervalued on forward earnings, but expensive on trailing metrics — a trough-margin valuation that only pays off if margins normalize.
Sign up to view all
SHOO 12-Month Price Forecast
SHOO presents a classic trough-margin valuation: cheap at 14.5x forward earnings and 1.17x sales, but only if the 44-46% gross margin and high-single-digit operating margin demonstrated in Q1 and Q3 2026 prove durable rather than episodic. The 17% post-earnings gap-down, -13.78 three-month relative strength, and failure to reclaim $40 mean the tape has not confirmed the fundamental case, even as 7 of 9 analysts rate the stock Buy with targets above the 52-week high. The wide $36-$60 target spread reflects genuine disagreement about margin recovery, not a tightly clustered high-conviction view. I would upgrade to bullish on a reclaim of $42-44 with volume plus a Q4 print showing DTC stabilization and gross margin above 44%, and downgrade to bearish if gross margin slips toward 42% or revenue growth decelerates below 10%.
Wall Street consensus
Coverage is solid for a $2.95 billion mid-cap, with 9 analysts publishing ratings: 7 Buy, 1 Hold, and 1 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 2.0. The average target price of $52.11 implies roughly 32% upside from the current $39.50, a wide gap that reflects how far the stock has fallen below where the Street models fair value — notably, the average target sits above the $49.70 52-week high, meaning analysts collectively expect the stock to make new highs. The consensus is clearly bullish, and the recent ratings flow supports that: Needham reiterated Buy on November 5 (the day of the Q3 print), BTIG reiterated Buy on October 27, and Piper Sandler, Citigroup, and UBS have all maintained their stances through the summer, with no downgrades in the visible record. The target range of $36.00 to $60.00 is wide — a 67% spread from low to high — which signals genuine disagreement about the margin-recovery trajectory rather than a tightly clustered, high-conviction view. The $60 high target likely assumes successful Dolce Vita-led growth, gross margins holding near the 44-46% level, and operating margins recovering toward double digits, which on $3.13 of EPS would justify a roughly 19x multiple. The $36 low target, about 9% below the current price, effectively prices in margin compression, continued international and DTC weakness, and a re-rating toward the low end of the historical band. With the stock having just gapped down 17% and the average target 32% above spot, the setup is one where the Street sees value but the tape has yet to confirm it — a classic "right on fundamentals, early on timing" configuration that argues for patience and confirmation before adding exposure.
Bulls vs Bears: SHOO Investment Factors
The bear case currently has the stronger near-term evidence: a 17% earnings gap-down, -13.78 relative strength over three months, and a failure to reclaim $40 all confirm sellers control the tape, while lagging international and DTC sales undercut the headline 15.68% revenue growth. The bull case rests on the forward math — 14.52x forward EPS of $3.13, a 7.2% FCF yield, and a $52.11 average target implying 32% upside — which is compelling but requires margin normalization that has not yet been demonstrated on a TTM basis (2.73% operating margin). The single most important tension is whether gross margins hold near the 44-46% level and operating margins recover toward the 9-10% seen in Q1 and Q3 2026; if they do, the forward multiple is cheap, but if promotional intensity pushes margins back toward Q4 2025's 42.43% gross and 4.80% operating level, the 14.5x forward multiple is not the bargain it appears. Until the stock reclaims $40-42 with volume and the next print confirms DTC stabilization, the risk/reward favors patience over aggression.
Bullish
- Forward PE of 14.5x is cheap: At $39.50, SHOO trades at just 14.52x forward EPS of $3.13 versus a distorted 66.1x trailing multiple, implying the market expects earnings to roughly quadruple off the depressed TTM base of $0.015. For a consumer brand growing revenue 15.68% YoY, a mid-teens forward multiple leaves limited room for further de-rating.
- Revenue accelerating through 2026: Q3 2026 revenue of $772.6 million rose 15.68% YoY from $667.9 million and marked the strongest quarter of the year, up sequentially from Q2's $665.9 million and Q1's $649.7 million. The $2.85 billion TTM run-rate is tracking toward the $2.86 billion consensus, and management raised 2026 guidance on Dolce Vita momentum.
- Analyst targets imply 32% upside: Seven of nine analysts rate SHOO Buy (recommendation mean 2.0) with an average target of $52.11, roughly 32% above the $39.50 spot and above the $49.70 52-week high. Needham and BTIG both reiterated Buy around the Q3 print, and no downgrades appear in the visible record.
- Margin recovery is real YoY: Q3 2026 net income of $52.4 million on a 6.78% net margin and 44.56% gross margin compares with just $20.5 million and 3.07% in Q3 2025, while Q3 operating margin reached 9.48%. Q1 2026 was even stronger at 54.49% gross and 11.06% net margin, showing the earnings power exists when volumes and mix cooperate.
Bearish
- 17% post-earnings gap-down: SHOO collapsed from $46.98 on November 4 to $38.995 on November 5 on 3.11 million shares, a roughly 17% single-session reset, and has failed to reclaim even $40, closing at $39.50. The stock is down 11.44% over one month and 18.69% over three months versus SPY's -4.99% and -4.91%, producing relative strength of -6.45 and -13.78.
- International and DTC channels lagging: The Q3 beat was driven by domestic wholesale strength while international and direct-to-consumer sales lagged, meaning the 15.68% headline growth overstates underlying momentum. With DTC at $255.4 million and Licensing a negligible $3.0 million, the segment mix remains uneven and dependent on a single geography.
- 2.73% operating margin is thin: TTM operating margin of 2.73% and net margin of 1.77% sit far below typical branded-footwear norms, and the quarterly path is volatile — Q1 2026 at 14.73% operating margin versus Q2 at 5.90% and Q4 2025 at 4.80%. The TTM figures absorbed the loss-making Q2 2025, when net income was -$39.5 million.
- Valuation stretched on trailing metrics: The 66.1x trailing PE sits at the very top of the stock's historical 8x-66x band, while EV/EBITDA of 26.9x and P/B of 3.41x look rich in absolute terms. The 1.17x PS ratio is cheap only relative to the 3.0x-6.2x range of 2021-2024, which itself reflects a persistent de-rating of the business.
SHOO Technical Analysis
SHOO is in a range-bound consolidation phase with a modestly positive longer-term tilt, having gained 2.92% over the past year while the S&P 500 rose 9.59%, a relative underperformance of 6.67 percentage points. At $39.50, the stock sits at roughly 45% of its 52-week range of $31.33 to $49.70 — closer to the midpoint than either extreme — which signals neither momentum-driven overextension nor a capitulation-style value setup, but rather a market awaiting a catalyst. The 32.14% max drawdown over the period underscores that this is a choppy, mean-reverting tape rather than a clean trend. Short-term momentum has deteriorated sharply and diverges from the flattish one-year picture: the stock is down 11.44% over the past month and 18.69% over three months, versus a 4.99% and 4.91% decline in SPY over the same windows, producing relative strength readings of -6.45 and -13.78. The most telling signal is the single-session collapse from $46.98 on November 4 to $38.995 on November 5 — a roughly 17% gap-down on heavy volume of 3.11 million shares following the Q3 print — followed by a tepid 1.30% bounce to $39.50. This looks like a sentiment reset rather than a gradual trend reversal, and the failure to reclaim even $40 in the sessions since suggests sellers remain in control near term. Key support sits at the 52-week low of $31.33, roughly 21% below the current price; a break there would confirm a deeper downtrend and likely trigger further momentum selling. Resistance is anchored at the $49.70 52-week high, about 26% above current levels, with an intermediate battleground around the $47-49 zone where the stock peaked in early August before rolling over. A beta of 1.166 means SHOO is roughly 17% more volatile than the market, so position sizing should account for amplified drawdowns — the recent 17% gap is a textbook example of why stop discipline matters more here than in a low-beta name.
Beta
—
—
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+9.9%
Cumulative gain past year
| Period | SHOO Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | -2.4% |
| 3m | -9.8% | -2.3% |
| 6m | +10.1% | +2.8% |
| 1y | +9.9% | +11.3% |
| ytd | +1.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHOO Fundamental Analysis
Revenue is growing at a healthy clip: Q3 2026 revenue of $772.6 million rose 15.68% year-over-year versus $667.9 million in Q3 2025, and the trailing four-quarter run-rate of roughly $2.85 billion is tracking toward the $2.86 billion consensus estimate for the year. The multi-quarter trend shows acceleration from Q2's $665.9 million and Q1's $649.7 million, with the Q3 figure the strongest of the year — though the segment mix is uneven, with Wholesale Footwear at $240.0 million and Direct-to-Consumer at $255.4 million leading, Wholesale Accessories/Apparel at $167.5 million, and Licensing a negligible $3.0 million. The key caveat, echoed in the Q3 coverage, is that domestic strength masked softness in international and DTC channels, so the headline growth rate may overstate underlying momentum. Profitability is thin but improving: Q3 net income of $52.4 million on a 6.78% net margin and 44.56% gross margin compares favorably to Q3 2025's $20.5 million and 3.07% net margin, a genuine year-over-year margin expansion story. However, the quarterly path is volatile — Q1 2026 posted a 54.49% gross margin and 11.06% net margin, Q2 fell to 46.50% and 4.16%, and Q4 2025 was just 42.43% and 3.08% — reflecting promotional intensity and cost deleverage in weaker quarters. The trailing operating margin of 2.73% and net margin of 1.77% on a TTM basis are well below the 9.48% operating margin reported in Q3 alone, confirming that the last twelve months absorbed a loss-making Q2 2025 (net income -$39.5 million). The balance sheet is solid: debt-to-equity of 0.56, current ratio of 1.90, and TTM free cash flow of $213.6 million against a $2.95 billion market cap imply an FCF yield of roughly 7.2%, a meaningful cushion. That said, cash generation is lumpy — Q3 2026 free cash flow was -$10.9 million on a $67.9 million working-capital drag and $14.4 million of capex, while Q2 generated $204.8 million — and ROE of just 5.15% is modest for a consumer brand, reflecting the low-margin wholesale mix and recent acquisition-related debt. The company funds its $15 million-plus quarterly dividend and modest buybacks internally, but the payout ratio of 1.36 signals distributions currently exceed earnings, a yellow flag worth monitoring.
Quarterly Revenue
$772606000.0B
2026-09
Revenue YoY Growth
+15.7%
YoY Comparison
Gross Margin
44.6%
Latest Quarter
Free Cash Flow
$213643000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHOO Overvalued?
Because net income is positive (TTM EPS of $0.015, Q3 net income of $52.4 million), the PE ratio is the appropriate primary metric, and here the picture is stark: the trailing PE of 66.1x versus a forward PE of 14.52x implies the market expects earnings to multiply roughly 4.5x over the next year, consistent with consensus EPS of $3.13 versus the depressed trailing figure. That enormous trailing-to-forward gap is the single most important valuation fact about SHOO — it tells you the trailing multiple is distorted by a weak earnings base (including the Q2 2025 loss) and that the forward multiple is the economically meaningful one. On that basis, 14.5x forward earnings is inexpensive for a growing consumer brand. Peer comparison reinforces the point: the PS ratio of 1.17x and EV/Sales of 1.11x are low in absolute terms for an apparel-footwear company with 15%+ revenue growth, while EV/EBITDA of 26.9x looks elevated only because EBITDA is depressed by the same trailing-earnings distortion. The 41.12% gross margin is respectable for the sector, but the 2.73% operating margin is well below typical branded-footwear norms, which explains why the market applies a low sales multiple — investors are paying for a margin-recovery story, not current profitability. Historical context is mixed: the stock's own PE history ranges from roughly 8x to 66x, and the current 66.1x trailing reading sits at the very top of that band, while the PS ratio of 1.17x is near the bottom of its multi-year range (historically 3.0x-6.2x in 2021-2024). That divergence — expensive on trailing earnings, cheap on sales — is the classic signature of a trough-margin year, and it means the valuation is only attractive if margins normalize toward the 9-10% operating levels seen in Q1 and Q3 2026.
PE
66.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~32x
vs. Industry Avg
21.8x
Industry PE ~21.8x*
EV/EBITDA
26.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin fragility and earnings quality. TTM operating margin of 2.73% and net margin of 1.77% are thin, and the quarterly swing from Q1 2026's 14.73% operating margin to Q2's 5.90% and Q4 2025's 4.80% shows how quickly promotional intensity erodes profitability. The 1.36 payout ratio means the 2.07% dividend exceeds earnings, and Q3 2026 free cash flow was -$10.9 million on a $67.9 million working-capital drag and $14.4 million of capex, so cash generation is lumpy despite a healthy $213.6 million TTM figure. Revenue concentration adds risk: Wholesale Footwear ($240.0 million) and DTC ($255.4 million) dominate the $772.6 million Q3 total, Licensing contributes only $3.0 million, and the majority of revenue comes from the US, so a domestic consumer slowdown or a single channel's weakness hits the whole P&L. ROE of 5.15% and debt-to-equity of 0.56 reflect acquisition-related leverage that limits flexibility if margins stay depressed.
Market and competitive risks are elevated by the stock's recent technical damage and premium trailing valuation. SHOO's beta of 1.166 makes it roughly 17% more volatile than the market, and the 17% single-session gap on November 5 on 3.11 million shares is a textbook example of amplified drawdown risk. The 66.1x trailing PE sits at the top of the historical 8x-66x band, so any disappointment risks multiple compression toward the low end, while the 1.17x PS ratio — cheap versus the 3.0x-6.2x range of 2021-2024 — shows the market has already de-rated the business on margin concerns. Competitive pressure in accessible-price footwear is intense, and the Q3 report's lagging international and DTC sales suggest the brand is not firing on all cylinders even as Dolce Vita builds momentum. A consumer cyclical with 6,300 employees and heavy department-store and mass-merchant wholesale exposure is also sensitive to retail inventory destocking and tariff or sourcing cost shifts.
Worst-case scenario: the margin recovery stalls, Q4 gross margin slips back toward the 42.43% level of Q4 2025, international and DTC weakness persists into the next print, and the Street re-rates the stock toward the $36 low target — about 9% below the current $39.50. A break of the $31.33 52-week low, roughly 21% below spot, would confirm a deeper downtrend and likely trigger momentum selling given the 1.166 beta and 4.14 short ratio. The 32.14% max drawdown over the past year is the relevant historical guide: from $39.50, a repeat of that magnitude implies a decline toward roughly $26.80, while the analyst bear case of $36 caps the modeled downside at about -9%. Realistically, an adverse scenario costs an investor 9% to 21% from current levels, with the tail risk extending toward -32% if the 52-week low fails.
FAQ
The most severe risk is margin fragility: TTM operating margin of 2.73% and net margin of 1.77% sit far below branded-footwear norms, and the quarterly path swung from 14.73% operating margin in Q1 2026 to 5.90% in Q2 and 4.80% in Q4 2025, so a return to Q4 2025's 42.43% gross margin would gut the forward earnings case. Second is channel and geographic concentration — the Q3 beat came from domestic wholesale while international and DTC lagged, and with Licensing at just $3.0 million of the $772.6 million quarter, the P&L depends on a narrow set of US wholesale and retail channels exposed to department-store destocking. Third is balance-sheet and distribution risk: the 1.36 payout ratio means the 2.07% dividend exceeds earnings, ROE is only 5.15%, and Q3 2026 free cash flow was -$10.9 million on a $67.9 million working-capital drag despite a healthy $213.6 million TTM figure. Fourth is market and technical risk — a 1.166 beta, a 4.14 short ratio, and a 32.14% max drawdown mean a break of the $31.33 52-week low could trigger momentum selling well beyond the -9% implied by the $36 analyst low target.
The 12-month outlook splits into three scenarios weighted 50/25/25. The base case (50% probability, $44-52) assumes revenue tracks the $2.86B consensus with mid-teens growth, gross margin normalizes to 43-45% and operating margin to 7-9%, and the stock grinds back toward the $52.11 average target as the post-earnings sentiment reset fades — returns come from earnings delivery, not re-rating. The bull case (25%, $52-60) requires Dolce Vita momentum to compound, DTC and international to stabilize by the Q4 print, and gross margin to hold 44-46% with operating margin recovering toward 9-10%, supporting a 17-19x multiple on $3.13 EPS and bracketed by the $52.11 average and $60 high targets. The bear case (25%, $31.33-36) assumes promotional intensity pushes gross margin back toward 42%, international and DTC weakness persists, and the Street re-rates toward the $36 low target, with a break of $31.33 risking the -32% drawdown analog near $26.80. The base case is most likely, and its key assumption is that the 44-46% gross margin demonstrated in Q1 and Q3 2026 is durable rather than episodic.
The answer depends entirely on which multiple you trust, and that divergence is the defining feature of the valuation. On trailing earnings the stock looks expensive at 66.1x PE, near the top of its historical 8x-66x band, with EV/EBITDA of 26.9x and P/B of 3.41x — but that trailing figure is distorted by the loss-making Q2 2025 and a 2.73% TTM operating margin. On forward earnings it looks cheap at 14.52x the $3.13 consensus EPS, and on sales it is near the bottom of its multi-year range at 1.17x PS and 1.11x EV/Sales versus the 3.0x-6.2x seen in 2021-2024. That combination — expensive trailing, cheap forward and on sales — is the classic signature of a trough-margin year, meaning the market is pricing in skepticism that the 44.56% gross margin of Q3 2026 persists. The verdict is fairly valued to modestly undervalued on forward earnings, but only conditionally: if margins normalize toward the 9-10% operating level seen in Q1 and Q3 2026, the current multiple is a discount; if gross margin reverts toward 42.43%, the 14.5x forward multiple is not the bargain it appears.
From a risk/reward standpoint the setup is asymmetric but unconfirmed. The upside case is anchored by a $52.11 average analyst target, roughly 32% above the $39.50 spot and above the $49.70 52-week high, with 7 of 9 analysts rating the stock Buy and a 14.52x forward multiple on $3.13 of estimated EPS. The downside is equally concrete: the analyst low target of $36 is about 9% below spot, the $31.33 52-week low is roughly 21% lower, and a repeat of the 32.14% max drawdown would imply a move toward $26.80. The biggest near-term risk is that the 17% post-earnings gap-down on November 5 reflects a genuine deterioration in international and DTC demand rather than a sentiment reset, and the stock's failure to reclaim $40 since suggests sellers still control the tape. For a patient investor with a 12-24 month horizon who sizes the position for a 1.166 beta, accumulating in tranches on confirmation of margin durability is reasonable; for a momentum trader or anyone needing income coverage, the 1.36 payout ratio and -13.78 three-month relative strength argue for waiting.
SHOO is better suited to a medium-to-long-term holding period of at least 12-24 months than to short-term trading. The thesis is explicitly a margin-normalization story — the gap between 14.52x forward and 66.1x trailing earnings only closes if the 44.56% gross margin and 9.48% operating margin of Q3 2026 repeat across quarters, which takes several prints to confirm. Short-term traders face a hostile tape: a 1.166 beta, a 17% single-session gap on November 5, -11.44% one-month and -18.69% three-month returns versus SPY's -4.99% and -4.91%, and relative strength of -13.78 over three months. The 2.07% dividend yield is a modest carry but not a reason to own the stock given the 1.36 payout ratio, and the 4.14 short ratio means crowded positioning can amplify moves in either direction. A reasonable approach is a staged entry with a minimum 12-month horizon, adding on a confirmed reclaim of $42-44 with volume and on a Q4 print showing DTC stabilization and gross margin above 44%, with a reassessment if gross margin slips toward 42%.